Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Tuberculosis Diagnostics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The tuberculosis diagnostics market has witnessed a CAGR of 4.56%. Factors propelling the growth of the market include the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, intensive product pipelines, and increasing government initiatives in the emerging markets.
The landscape of TB diagnostics has changed dramatically during the past ten years. Moreover, in response to WHO’s Global TB Programme, it has implemented a systematic and dynamic process, that is used to evaluate technologies and develop policies, which has, thus, enhanced the growth of the market.
The prevalence rate of tuberculosis is also increasing every year, along with the number of government awareness programs that are influencing people to opt for diagnostic tests (like radiographic tests), which are expected to drive the market during the forecast period.
The market is also expected to witness growth as there is an opportunity for players in the market studied to accelerate the market approval of their pipeline diagnostic products by spurring the fundamental research in TB. Additionally, technological developments in fields, like genomics and proteomics, can be leveraged by diagnostic providers to hasten the process of product development in TB diagnostics.
Scope of the Report
Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in emerging economies. The government initiatives for promoting diagnoses in TB are increasing globally, as governments of various regions are beginning to understand the gap areas in TB management.
Key Market Trends
Nucleic Acid Testing is expected to hold its Highest Market Share among the Diagnostic Tests
In the application type segmentation of the tuberculosis diagnostics market nucleic acid testing is believed to have the largest market size, and is expected to witness a CAGR of 5.4% during the forecast period. This can be attributed to the nucleic acid amplification tests (NAATs) that have been used as diagnostic tools for tuberculosis (TB) in the United States since many years, and which still continue to be used. There are substantial advancements in the diagnosis of TB. Moreover, hese tests have been commercially available in the United States for over two decades that offer better accuracy than other microscopy tests, and even provide greater speed than culture-based tests.
The smear laboratory test is also highly specific in areas with a very high prevalence of tuberculosis. Further, the increasing prevalence rate of TB and advancements in culture-based tests are also expected to drive the market during the forecast period.
Asia-Pacific is the Largest Regional Tuberculosis Diagnostics Market and is expected to be the Same in the Forecast Period
Asia-Pacific is anticipated to exhibit profitable growth over the forecast period due to its high burden as well the rapid proliferation of this disease. The increasing prevalence of TB in Japan helps in the growth of the TB diagnostics market, as the high prevalence of TB creates an urgent demand for effective and quick diagnosis of the disease.
In addition, according to the recent budget announcement, Government of India aims to eliminate tuberculosis (TB) by 2025, which is expected to act as a major factor for the growth of the Asia-Pacific market during the forecast period.
Competitive Landscape
The new product launches, collaborations, mergers and acquisitions, and regional expansions are the key strategic initiatives undertaken by these industry players. The major global players in the tuberculosis diagnostics market are Abbott, Becton, Dickinson and Company, BioMérieux SA, Cepheid, and F. Hoffmann-La Roche AG, among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Tuberculosis and Multidrug-resistant Tuberculosis (MDR-TB)
4.2.2 Increasing R&D Investments and Intensive Product Pipelines
4.2.3 Increasing Government Initiatives and Rising Awareness in the Emerging Markets
4.3 Market Restraints
4.3.1 High Costs Associated with Tuberculosis Diagnostics
4.3.2 Low Coverage or Absence of Insurance in the Emerging Markets
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Diagnostic Test Type
5.1.1 Radiographic Test
5.1.2 Laboratory Test
5.1.3 Nucleic Acid Testing
5.1.4 Cytokine Detection Test
5.1.5 Drug Resistance Test
5.1.6 Other Diagnostic Test Types
5.2 By End User
5.2.1 Hospital/Clinics
5.2.2 Diagnostics/Research Laboratory
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 BioMerieux SA
6.1.4 Cepheid
6.1.5 F. Hoffmann-La Roche AG
6.1.6 Hain Lifescience GmbH
6.1.7 Hologic Corporation
6.1.8 Qiagen
6.1.9 AdvaCare Pharma
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Diagnostic Test Type
Radiographic Test
Laboratory Test
Nucleic Acid Testing
Cytokine Detection Test
Drug Resistance Test
Other Diagnostic Test Types
By End User
Hospital/Clinics
Diagnostics/Research Laboratory
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South Americ
UAE Dental Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 71 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 71 pages
- Published: 07-06-2019
Market Overview
The UAE dental devices market is expected to record a CAGR of approximately 6.62% over the forecast period, 2019-2024. Certain factors that are accelerating the growth of this market include increasing awareness on oral care, increasing incidences of dental diseases, and innovation in dental products in the United Arab Emirates.
Innovation in dental products has been an impactful factor that is shaping the UAE dental devices market positively.
In the past decade, the major focus in dentistry has been toward dental innovations to improve oral health through a combination of engineering, art, science, and technology. Computer Aided Design/Computer Aided Milling (CAD/CAM) is a technological innovation that has revolutionized dental care and patient experience.
A structurally damaged tooth, by decay or trauma, should be “crowned†or “cappedâ€, for it to function properly and avoid infections. A crown is a durable covering that is custom-made, usually in a dental laboratory, to fit over the entire tooth. CAD/CAM allows the manufacture of crowns immediately within the clinic or hospital. The machine makes it possible to fabricate laboratory-grade crowns and other dental restorations in minutes, whereas, the traditional crowns take two to three visits, with many weeks of waiting.
One of the most effective uses of CAD/CAM is the same-day porcelain crown, which eliminates several steps, including using a temporary plastic crown while the permanent crown is being made in the laboratory. Since people across the United Arab Emirates are more specific regarding appearance, there is an increasing demand for the dental corrections with the help of such novel methods, which in turn, is augmenting the growth of the dental devices market.
Scope of the Report
Dental instruments are tools that dental professionals use to provide dental treatment. They include tools to examine, manipulate, treat, restore, and remove teeth and surrounding oral structures. Standard instruments are the instruments used to examine, restore, and extract teeth, and manipulate tissues.
Key Market Trends
The Crown and Bridge Sub-segment in the General and Diagnostic Equipment Segment is Expected to Witness Highest Growth Rate
The crown and bridge sub-segment in the general and diagnostic equipment segment of the UAE dental devices market is expected to witness the highest CAGR during the forecast period.
A dental bridge is used to fill the gap created by one or more missing teeth. The crown or bridge is manufactured manually or with the help of CAD/CAM technology. Currently, CAD/CAM software is gaining popularity, owing to its accuracy in determining the dimensions of the crown or bridge. This software tool also speeds up the process and reduces the cost of treatment.
Owing to its significance and the adoption, there is a rise in the demand of crown and bridge in the United Arab Emirates, which is likely to contribute to the faster growth of the sub-segment in the future.
Competitive Landscape
The UAE dental devices market is moderately competitive with the inclusion of some big players, such as Carestream, Zimmer Biomet, Danaher Corporation, 3M, and Dentsply Sirona. Along with these players, there are few small companies that are also penetrating the market and holding a substantial share in it.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Awareness on Oral Care
4.2.2 Increasing Incidences of Dental Diseases
4.2.3 Innovation in Dental Products
4.3 Market Restraints
4.3.1 High Cost of the Surgeries
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 General and Diagnostic Equipment
5.1.1.1 Dental Implant
5.1.1.2 Crown and Bridge
5.1.1.3 Dental Laser
5.1.1.3.1 Soft Tissue Lasers
5.1.1.3.2 Hard Tissue Lasers
5.1.1.4 Other Product Types
5.1.2 Radiology Equipment
5.1.2.1 Extra Oral Radiology Equipment
5.1.2.2 Intra Oral Radiology Equipment
5.1.3 Dental Biomaterial
5.1.4 Dental Chair and Equipment
5.1.5 Dental Consumables
5.1.6 Other Dental Devices
5.2 By Treatment
5.2.1 Orthodontic
5.2.2 Endodontic
5.2.3 Peridontic
5.2.4 Prosthodontic
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Other End Users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Carestream Health
6.1.3 Danaher Corporation
6.1.4 Dentsply Sirona
6.1.5 Straumann Holding AG
6.1.6 Zimmer Biomet
6.1.7 Sirona Dental Systems Inc.
6.1.8 Geistlich Holding
6.1.9 Ivoclar Vivadent AG
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
General and Diagnostic Equipment
Dental Implant
Crown and Bridge
Dental Laser
Soft Tissue Lasers
Hard Tissue Lasers
Other Product Types
Radiology Equipment
Extra Oral Radiology Equipment
Intra Oral Radiology Equipment
Dental Biomaterial
Dental Chair and Equipment
Dental Consumables
Other Dental Devices
By Treatment
Orthodontic
Endodontic
Peridontic
Prosthodontic
By End User
Hospitals
Clinics
Other End Users
UAE In-Vitro Diagnostics Market – Growth, Trends & Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 85 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 85 pages
- Published: 07-06-2019
Market Overview
The growth of the UAE IVD market can be attributed to the high prevalence of chronic and infectious diseases. Chronic diseases are a growing global challenge, and according to WHO estimates, account for approximately 60% of all deaths, worldwide. In addition, WHO states that chronic diseases, such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases are responsible for 12%, 40%, 5%, and 5% of mortality in the United Arab Emirates. The current market is also growing due to the use of advanced technologies in the IVD market. There has been a paradigm shift from traditional diagnostics to a new generation diagnostics, that works at the gene level. This was made possible by the inclusion of advanced technologies, such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS).
Scope of the Report
In-vitro diagnostics involves medical devices and consumables that are utilized to perform in-vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases.
Key Market Trends
Reagents Segment holds the Largest Market Share in the Product Type Segment
Reagents capture the largest market share and are expected to exhibit the fastest growth rate over the forecast period, owing to repeat purchase and increasing demand. The reagent segment of the market studied includes chemical, biological, or immunological components, solutions, and preparations intended by the manufacturer to be used during the in-vitro diagnostic process. Given the high cost of many diagnostic platforms, it is common for manufacturers to lease equipment instead of selling technology outright to end users. In these arrangements, the lease is tied to contracts to purchase associated reagents or assay kits for the equipment over the life of the contract.
Many diagnostic companies have in excess of 75% of sales from consumables, such as assays and reagents, and such agreements guarantee the generation of cyclic revenues associated with the sale of reagents and other consumables. Reagent usage for IVD kits often carry high costs,;hence, the availability of immunodiagnostic services in developing countries is often limited by the high cost of imported kits. Many developing countries have established local immunoassay reagent programs to manufacture low-cost, high-quality immunoassay reagents. Kits from these projects are now beginning to become available and are likely to fuel the market expansion.
Competitive Landscape
The major market players in the UAE in-vitro diagnostics market are bioMérieux, Qiagen, Abbott Laboratories, and Roche Diagnostics, and Siemens among others. The competition among manufacturers is increasing, with the increasing number of companies. Small manufacturers represent an unorganized market due to the lower prices of their products.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Chronic Diseases
4.2.2 Increasing Use of Point-of-care (POC) Diagnostics
4.2.3 Technological Advancements
4.2.4 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Cumbersome Reimbursement Procedures
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Technique
5.1.1 Immunochemistry
5.1.2 POC Diagnostics
5.1.3 Molecular Diagnostics
5.1.4 Hematology
5.1.5 Tissue Diagnostics
5.1.6 Microbiology
5.1.7 Self-blood Glucose Monitoring
5.1.8 Other Techniques
5.2 By Product
5.2.1 Instrument
5.2.2 Reagent
5.2.3 Data Management System
5.3 By Usablity
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.2 Diabetes
5.4.3 Cancer/Oncology
5.4.4 Cardiology
5.4.5 Autoimmune Disease
5.4.6 Nephrology
5.4.7 Drug Testing
5.4.8 HIV/AIDS
5.4.9 Other Applications
5.5 End User
5.5.1 Laboratory & Academia
5.5.2 Hospitals and POC Testing Centers
5.5.3 Other End Users
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 bioMérieux
6.1.4 Bio-Rad Laboratories, Inc.
6.1.5 Danaher Corporation
6.1.6 Qiagen
6.1.7 F. Hoffmann-La Roche Ltd
6.1.8 Siemens Healthcare GmBH
6.1.9 Sysmex Corporation
6.1.10 Thermo Fisher Scientific
7. Market Opportunities and Future Trends
Market Segmentation
- By Technique
Immunochemistry
POC Diagnostics
Molecular Diagnostics
Hematology
Tissue Diagnostics
Microbiology
Self-blood Glucose Monitoring
Other Techniques
By Product
Instrument
Reagent
Data Management System
By Usablity
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Drug Testing
HIV/AIDS
Other Applications - End User
Laboratory & Academia
Hospitals and POC Testing Centers
Other End Users
UK Wound Care Management Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 72 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 72 pages
- Published: 07-06-2019
Market Overview
The growth of the wound care management devices market is attributed due to the increase in the geriatric population, rising incidences of a chronic wound, and an increase in the number of surgeries.
In the United Kingdom, the prevalence of diabetes is around 6% of the overall population. According to the National Institute of Health, 1 in every 16 people in the United Kingdom is suffering from diabetes. Nearly one-third of the diabetics develop foot ulceration within a year of diagnosis. Diabetic foot’ refers to an infection, ulceration, and possible amputation of a foot or leg among diabetics. This infection, usually, is diagnosed in its later stages, which poses adverse socio-economic consequences for patients and their families. Extensive surveys indicate that about 40-70% of all lower extremity amputations are related to diabetes. Incidences of chronic wounds, especially foot ulcers, are common among the diabetic population. While more than 80,000 adults are expected to undergo a lower extremity amputation, diabetics are 10 times more likely to undergo amputation at some point in their lifetime. The diabetic population is likely to grow in the United Kingdom, which, in turn, is anticipated to drive the market for wound care management devices during the forecast period.
Scope of the Report
As per the scope of this report, the term wound care management is the utilization of different products and technologies for the healing of wounds. In simple words, it is the treatment given for both acute and chronic wounds.
Key Market Trends
Long-term Care Facility is the Segment Under Deployment that is Expected to Grow Fastest during the Forecast period
The hospital and specialty wound clinic segment held a maximum share in 2018. This segment holds the largest share, owing to high demand for these devices in all types of healthcare centers and including out-patient centers, specialty hospitals, and community health centers. High rate of hospitalizations and increase in demand for surgeries, especially minimally invasive surgeries, are the key factors responsible for the high demand for wound management devices and consumables in hospitals and all other healthcare settings. The long-term care facility segment is forecast to show significant growth during the forecast period.
Competitive Landscape
The UK wound care management devices market is moderately competitive and consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help them in strengthening their market position. For instance, in December 2017, Smith & Nephew announced the European launch of MolecuLight i:X, which is a handheld imaging device that can be used to instantly measure wound surface area and visualize the presence of potentially harmful bacteria in it.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in the Geriatric Population
4.2.2 Rising Incidences of Chronic Wound
4.2.3 Increase in the Number of Surgeries
4.3 Market Restraints
4.3.1 High-cost Procedures
4.3.2 Lack of Proper Reimbursements
4.3.3 Reluctance toward the Acceptance of New Technologies
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Advanced Wound Management Product
5.1.1.1 Advanced Wound Dressing
5.1.1.1.1 Foam Dressing
5.1.1.1.2 Hydrocolloid Dressing
5.1.1.1.3 Film Dressing
5.1.1.1.4 Alginate Dressing
5.1.1.1.5 Hydrogel Dressing
5.1.1.1.6 Other Advanced Dressings
5.1.1.2 Wound Therapy Device
5.1.1.2.1 Pressure Relief Device
5.1.1.2.2 Negative Pressure Wound Therapy (NPWT) System
5.1.1.2.2.1 Conventional NPWT System
5.1.1.2.2.2 Disposable NPWT System
5.1.1.2.3 Oxygen and Hyperbaric Oxygen Equipment
5.1.1.2.4 Electrical Stimulation Device
5.1.1.2.5 Other Therapy Devices
5.1.1.3 Surgical Wound Care Product
5.1.1.3.1 Suture and Staple
5.1.1.3.2 Tissue Adhesive, Sealant, and Glue
5.2 End User
5.2.1 Hospital and Specialty Wound Clinic
5.2.2 Long-term Care Facility
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Johnson & Johnson
6.1.2 KCI Inc.
6.1.3 3M
6.1.4 Smith &Nephew
6.1.5 Convatec Inc.
6.1.6 Medtronic plc
6.1.7 Beiersdorf
6.1.8 Coloplast A/S
6.1.9 Molnlycke Health Care
6.1.10 Derma Sciences
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Advanced Wound Management Product
Advanced Wound Dressing
Foam Dressing
Hydrocolloid Dressing
Film Dressing
Alginate Dressing
Hydrogel Dressing
Other Advanced Dressings
Wound Therapy Device
Pressure Relief Device
Negative Pressure Wound Therapy (NPWT) System
Conventional NPWT System
Disposable NPWT System
Oxygen and Hyperbaric Oxygen Equipment
Electrical Stimulation Device
Other Therapy Devices
Surgical Wound Care Product
Suture and Staple
Tissue Adhesive, Sealant, and Glue
End User
Hospital and Specialty Wound Clinic
Long-term Care Facility
Ultrasound Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the ultrasound devices market include the government and private funding for R&D in ultrasound imaging, increasing number of healthcare providers, technological advancements, and increasing incidences of chronic diseases.
The incidences and prevalence of chronic diseases are rapidly increasing all around the world. Currently, affecting more than 14 million people around the world, the prevalence of cancer is becoming a major concern for the healthcare sectors across the world. The demand for ultrasound imaging devices is expected to rise, along with the demand for the early detection of disease and minimization of the cost of treating these chronic diseases. This also increases the number of diagnostic imaging procedures. The significant contribution to medical diagnostics and the ease of use have created a huge demand, and therefore, attracted various funding bodies to invest, which is expected to increase in the coming years.
The rising technological advancements supported by the adoption of trusted associations are expected to boost market growth. Curtailment in the size of ultrasound devices has given the market a slight boost, if not a significant one. It has given the healthcare facilities a chance to replace old heavy devices with small devices. With the reduction in the size of these devices, the problem of storage is solved, enabling the facilities to operate more efficiently with more number of devices.
Scope of the Report
As per the scope of the report, a diagnostic ultrasound, also known as sonography, is an imaging technique that uses high-frequency sound waves to produce images of the different structures inside the body. They are being utilized for the assessment of various conditions in the kidney, liver, and other abdominal conditions. They are also majorly used in chronic diseases, which include health conditions, such as heart disease, asthma, cancer, and diabetes. Therefore, these devices are being utilized as both diagnostic imaging and therapeutic modality, and have a wide range of applications in the medical field.
Key Market Trends
3D and 4D ultrasound imaging is the segment under technology that expected to grow fastest during the forecast period
3D and 4D ultrasound imaging take images at various angles, as compared to a single angle by 2D ultrasound. 4D ultrasound has added advantages of visualization and motion. It is widely used for abdominal applications, including the detection of abnormal fetus development, visualization of colon and rectum, detection of cancerous and benign tumours of prostate glands, and breast lesions, along with the flow of blood in various organs or a fetus. These ultrasounds are likely to experience substantial growth in the coming years, with the higher adoption of technologically advanced devices for better clinical decisions. Additionally, this segment is anticipated to gain more share and emerge as the fastest-growing segment during the forecast period. The 3D and 4D ultrasound imaging segment is expected to witness a CAGR of 4.27% over the forecast period.
The Doppler imaging ultrasound technique is widely adopted, due to its advancements, and is used to estimate the blood flow through blood vessels by high-frequency sound waves.
Asia-Pacific holds the largest market share of the market and is expected to follow the same trend over the forecast period
The Asia-Pacific region is expected to witness higher growth, due to the government and private funding for R&D and an increase in the number of healthcare providers. The ultrasound devices market in Asia-Pacific is anticipated to expand, due to the increase in awareness about ultrasound devices for diagnostic and therapeutic applications. Moreover, the expansion of the healthcare sector in countries, such as China, Japan, and India, offers immense potential in this region. The growing ageing population in Japan and China and technological advancements, like portability and 3D ultrasound attached to smart devices, have further fueled the growth of the market.
Competitive Landscape
The public and private companies are found investing in R&D of advanced innovative technologies in the field of ultrasound imaging, as it is becoming one of the fundamental aspects of healthcare. Some of the major companies invested in ultrasound devices are Philips, Siemens, SonoSite Inc., and Clarius. Their updated technological portable devices are praised globally and these companies have a wide presence across the developed and emerging markets.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Government and Private Funding for R&D in Ultrasound Imaging
4.2.2 Increasing Number of Healthcare Providers
4.2.3 Technological Advancements
4.2.4 Increasing Incidences of Chronic Diseases
4.3 Market Restraints
4.3.1 Strict Regulations
4.3.2 Lack of Skilled Labor to Handle the Advanced Equipment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Anesthesiology
5.1.2 Cardiology
5.1.3 Gynecology/Obstetrics
5.1.4 Musculoskeletal
5.1.5 Radiology
5.1.6 Emergency Department
5.1.7 Critical Care
5.1.8 Other Applications
5.2 By Technology
5.2.1 2D Ultrasound Imaging
5.2.2 3D and 4D Ultrasound Imaging
5.2.3 Doppler Imaging
5.2.4 High-intensity Focused Ultrasound
5.3 By Type
5.3.1 Stationary Ultrasound
5.3.2 Portable Ultrasound
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Fujifilm Holdings Corporation
6.1.2 GE Healthcare
6.1.3 Hitachi Medical Corporation
6.1.4 Mindray Medical International Ltd
6.1.5 Koninklijke Philips NV
6.1.6 Hologic, Inc.
6.1.7 Siemens Healthineers
6.1.8 Canon Medical Systems Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Application
Anesthesiology
Cardiology
Gynecology/Obstetrics
Musculoskeletal
Radiology
Emergency Department
Critical Care
Other Applications
By Technology
]2D Ultrasound Imaging
3D and 4D Ultrasound Imaging
Doppler Imaging
High-intensity Focused Ultrasound
By Type
Stationary Ultrasound
Portable Ultrasound
Geography
North America
United States
Canada
Mexico
]Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South Americz
Urology Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The global urology devices market was valued at USD 30,967.15 million in 2018, and is estimated to be valued at USD 44,804.97 million in 2024, witnessing a CAGR of 6.35%. The key factors propelling the market growth include high incidence of urologic conditions, rising geriatric population, and technological advancements.
According to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIS), and kidney and ureteral stones are among the most common urological diseases. According to the United States Department of Health and Human Services, the overall prevalence of CKD among the American population is about 14%, and almost half of the individuals with CKD suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis. Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with it. With a global increase in diabetic population, complications, like dysuria and organ damage that are associated with UTIs, are also on the rise.
With high incidence rates and health complications associated with urological diseases, there is an increasing demand for healthcare interventions to manage them, which, in turn, is propelling the market of urology surgical and diagnostic devices.
Scope of the Report
This report estimates the global urology devices market (henceforth, referred to as the market studied). It includes a detailed analysis of urological devices, consumables, and accessories, along with the areas in which they are being used and their end users.
Urological conditions include kidney stone disease (urolithiasis), incontinence in men and women, benign prostate hyperplasia (BPH, noncancerous swelling of prostate occurring in men with increasing age, prostate cancer, and erectile dysfunction in men, etc.
Key Market Trends
Kidney Disease is Expected to hold its Highest Market Share in the Disease Segment
In the disease segment of the urology devices market, kidney disease is believed to have the largest market size and is expected to witness a CAGR of 6.47% during the forecast period.
The various kidney diseases include renal cyst, cystic kidney diseases, chronic kidney disease, hemolytic-uremic syndrome, and lupus nephrite, among others. Most of the kidney diseases lead to kidney failure, which requires early diagnosis for prompt treatment.
According to the statistics by the National Kidney Foundation, in 2015, it was estimated that chronic kidney diseases affected approximately 10% of the world’s population. However, most of this population remain undiagnosed in the early stages, eventually leading to death, worldwide. According to the Global Burden of Disease study, in 2010, chronic kidney disease ranked 18th as the cause for the total number of deaths, worldwide.
An increase in awareness, along with support from the government through reimbursement, and innovation in products, in order to develop low-cost and effective treatment, are some elements that are expected to drive the market, over the forecast period. The highest growth rate is seen in the Asia-Pacific countries that are contributed by India and China, due to the increasing patient pool, availability of local low-cost products, and rapid adoption of urology devices.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America currently dominates the market for urology devices and is expected to continue its stronghold for a few more years. Benign prostatic hyperplasia (BPH) is among the most untapped segments in the urology market, with several US-based companies working on upgrading their devices in this segment, either by collaboration or acquisition. Recently, in 2018, Boston Scientific Corporation acquired NxThera and its RezÅ«m benign prostatic hyperplasia device. Additionally, several ventures partners, as well as other investors have funded significantly for minimally invasive devices for the treatment of urology diseases. For instance, Zenflow received USD 31.4 million funding, while UroCure, a medical device startup raised USD 2.5 million for urethral slings, in 2018. The technology was acquired by Endo International’s subsidiary, American Medical Systems Holdings.
Thus, over the forecast period, technological advancements, a high percentage of urology cases in hospitals, and increasing funding are expected to be the major drivers for the growth of the urology devices market.
Competitive Landscape
The urology devices market is highly competitive and consists of several major players. With increasing technological advancements and product innovations, mid-size to smaller companies are expected to increase their market presence by introducing new devices with lesser prices. Companies, like Baxter, Boston Scientific, C. R. Bard, Medtronic, and Siemens, hold the substantial share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Incidence of Urologic Conditions
4.2.2 Rising Geriatric Population
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Stringent Regulatory Policies for Validation of Medical Devices
4.3.2 High Cost of Urology Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.1.1 Dialysis Devices
5.1.1.2 Endoscopes and Endovision Systems
5.1.1.3 Lasers and Lithotripsy Devices
5.1.1.4 Robotic Systems
5.1.1.5 Peripheral Instruments
5.1.1.6 Urodynamic Systems
5.1.2 By Consumables and Accessories
5.1.2.1 Dialysis Consumables
5.1.2.2 Guidewires
5.1.2.3 Surgical Dissectors, Forceps, and Needle Holders
5.1.2.4 Retrieval Devices and Extractors
5.1.2.5 Catheters
5.1.2.6 Stents
5.1.2.7 Biopsy Devices
5.1.2.8 Tubes and Distal Attachments
5.1.2.9 Dilator Sets and Urethral Access Sheaths
5.1.2.10 Drainage Bags
5.1.2.11 Other Consumables and Accessories
5.2 By Disease
5.2.1 Kidney Diseases
5.2.2 Urological Cancer and BPH
5.2.3 Pelvic Organ Prolapse
5.2.4 Other Diseases
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Dialysis Centers
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Baxter International Inc.
6.1.2 Boston Scientific Corporation
6.1.3 C. R. Bard Inc.
6.1.4 Cook Medical Incorporated
6.1.5 Dornier MedTech GmbH
6.1.6 Fresenius Medical Care AG & Co. KGaA
6.1.7 Intuitive Surgical Inc.
6.1.8 Karl Storz SE & Co. KG
6.1.9 Medtronic PLC
6.1.10 Olympus Corporation
6.1.11 Richard Wolf GmbH
6.1.12 Siemens Healthcare GmbH
6.1.13 Stryker Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Instruments
Dialysis Devices
Endoscopes and Endovision Systems
Lasers and Lithotripsy Devices
Robotic Systems
Peripheral Instruments
Urodynamic Systems
By Consumables and Accessories
Dialysis Consumables
Guidewires
Surgical Dissectors, Forceps, and Needle Holders
Retrieval Devices and Extractors
Catheters
Stents
Biopsy Devices
Tubes and Distal Attachments
Dilator Sets and Urethral Access Sheaths
Drainage Bags
Other Consumables and Accessories
By Disease
Kidney Diseases
Urological Cancer and BPH
Pelvic Organ Prolapse
Other Diseases
By End User
Hospitals and Clinics
Dialysis Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America